Table 3.
Summary of typhoid vaccine economic evaluation types.
Characteristic | Number of studies (n = 7) | Reference |
---|---|---|
Based on field studies | 5 | [27], [28], [29], [30], [31] |
Perspective: | ||
Public sector only | 2 | [27], [32] |
Private only | 1 | [29] |
Societal (public and private) | 4 | [28], [29], [30], [31], [33] |
Include intangible costs of pain, suffering and disability | 3 | [28], [30] |
Analytical approach: (a study can include more than one approach) | ||
Cost-benefit analysis component | 4 | [29], [30], [31], [32] |
Cost-effectiveness analysis component | 2 | [27], [32] |
Cost-utility analysis component | 2 | [30], [33] |
Willingness-to-pay component | 4 | [27], [28], [29] |
Price-optimisation model | 1 | [27] |
Include indirect protection of vaccines | 1 | [27] |
Include transmission dynamics | 0 | |
Evaluates improve sanitation, hygiene or water supply as an alternative to or adjunct to vaccination | 0 |